不応性慢性リンパ性白血病:グローバル臨床試験レビュー(2014年上半期)...市場調査レポートについてご紹介

【英文タイトル】Refractory Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
Introduction 7
Refractory Chronic Lymphocytic Leukemia (CLL) 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Refractory Chronic Lymphocytic Leukemia (CLL) to Oncology Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Refractory Chronic Lymphocytic Leukemia (CLL) to Oncology Clinical Trials 19
Clinical Trials by Phase in E7 Countries 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Refractory Chronic Lymphocytic Leukemia (CLL) 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Refractory Chronic Lymphocytic Leukemia (CLL) Therapeutics Clinical Trials 30
Prominent Drugs 32
Latest Clinical Trials News on Refractory Chronic Lymphocytic Leukemia (CLL) 33
Nov 25, 2013: TG Therapeutics Initiates First Combination Clinical Trial of TG-1101 and TGR-1202 in Patients With Relapsed and/or Refractory CLL and NHL 33
Oct 07, 2013: MorphoSys and Xencor Provide Update on Phase 1/2a Trial in CLL/SLL for MOR208 33
Jun 01, 2009: Trubion Announces Positive Data From A Phase I / II Study Of TRU-016 For The Treatment Of Chronic Lymphocytic Leukemia (CLL) 34
Clinical Trial Profiles 36
Clinical Trial Overview of Top Companies 36
F. Hoffmann-La Roche Ltd. 36
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 36
Celgene Corporation 38
Clinical Trial Overview of Celgene Corporation 38
Pharmacyclics, Inc. 39
Clinical Trial Overview of Pharmacyclics, Inc. 39
Janssen Global Services, LLC 40
Clinical Trial Overview of Janssen Global Services, LLC 40
GlaxoSmithKline plc 41
Clinical Trial Overview of GlaxoSmithKline plc 41
AbbVie Inc. 42
Clinical Trial Overview of AbbVie Inc. 42
Gilead Sciences, Inc. 43
Clinical Trial Overview of Gilead Sciences, Inc. 43
Sanofi 44
Clinical Trial Overview of Sanofi 44
Merck & Co., Inc. 45
Clinical Trial Overview of Merck & Co., Inc. 45
Clinical Trial Overview of Top Institutes / Government 46
National Cancer Institute 46
Clinical Trial Overview of National Cancer Institute 46
Fred Hutchinson Cancer Research Center 48
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 48
The University of Texas M. D. Anderson Cancer Center 49
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 49
Case Comprehensive Cancer Center 50
Clinical Trial Overview of Case Comprehensive Cancer Center 50
Roswell Park Cancer Institute 51
Clinical Trial Overview of Roswell Park Cancer Institute 51
Ohio State University Comprehensive Cancer Center 52
Clinical Trial Overview of Ohio State University Comprehensive Cancer Center 52
Mayo Clinic 53
Clinical Trial Overview of Mayo Clinic 53
Beth Israel Deaconess Medical Center 54
Clinical Trial Overview of Beth Israel Deaconess Medical Center 54
Massachusetts General Hospital 55
Clinical Trial Overview of Massachusetts General Hospital 55
Duke University 56
Clinical Trial Overview of Duke University 56
Five Key Clinical Profiles 57
Appendix 195
Abbreviations 195
Definitions 195
Research Methodology 196
Secondary Research 196
About GlobalData 197
Contact Us 197
Disclaimer 197
Source 198


【レポート販売概要】

■ タイトル:不応性慢性リンパ性白血病:グローバル臨床試験レビュー(2014年上半期)
■ 英文:Refractory Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2014
■ 発行日:2014年4月15日
■ 調査会社:GlobalData
■ 商品コード:GDHC2082CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。